January 2017

Amyotrophic Lateral Sclerosis (ALS) is a neurological disease that affects ... 90–95% of the overall cases in US and the government initiatives to examination the research for rare disease and FDA approvals creates an opportunity for various market ...

The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Amyotrophic Lateral Sclerosis (Central Nervous System) pipeline guide also reviews of key ...

Some of the major market players in amyotrophic lateral sclerosis market include Mitsubishi Tanabe Pharma, Avicena Inc., Sanofi Inc., Biogen Inc. and others. This research report analyzes this market depending on its market segments, major geographies ...

Editor’s Note: This study review confirms the findings of many Lyme-literate doctors and other research studies ... variety of chronic degenerative diseases, including Amyotrophic lateral sclerosis (ALS), Multiple Sclerosis (MS), and Alzheimer's disease ...